• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向Ha-ras的修饰寡核苷酸的核酸酶抗性和反义活性

Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras.

作者信息

Monia B P, Johnston J F, Sasmor H, Cummins L L

机构信息

Department of Molecular Pharmacology and Division of Medicinal Chemistry, Isis Pharmaceuticals, Carlsbad, California 92008, USA.

出版信息

J Biol Chem. 1996 Jun 14;271(24):14533-40. doi: 10.1074/jbc.271.24.14533.

DOI:10.1074/jbc.271.24.14533
PMID:8662854
Abstract

We have previously described structure-activity studies on a 17-mer uniform phosphorothioate antisense sequence targeted to human Ha-ras. In an effort to further improve the pharmacological properties of antisense oligonucleotides, structure-activity studies on this 17-mer sequence were expanded to examine both the effects of replacing phosphorothioate backbone linkages with phosphodiester linkages and the effects of incorporating various 2'-sugar modifications into phosphorothioate and phosphodiester oligonucleotides on oligonucleotide stability against nucleases in vitro and on antisense activity in cells. Replacement of three or more phosphorothioate linkages with phosphodiester linkages greatly compromised both nuclease resistance and antisense activity, and these effects correlated directly with the number of phosphodiester linkages incorporated into the oligonucleotide. However, substantial nuclease resistance, sufficient for obtaining potent antisense effects in cells, was conferred to phosphodiester oligonucleotides by incorporation of appropriate 2'-alkoxy sugar modifications. Nuclease stability and antisense activity imparted by these sugar modifications in phosphodiester backbones correlated with the size of the 2'-alkoxy substituent (pentoxy > propoxy > methoxy > deoxy). Furthermore, antisense activity mediated by oligonucleotides that exhibit partial resistance to nucleolytic degradation was dependent on both oligonucleotide concentration and the duration of oligonucleotide treatment.

摘要

我们之前曾描述过针对人Ha-ras的17聚体均匀硫代磷酸酯反义序列的构效关系研究。为了进一步改善反义寡核苷酸的药理特性,对该17聚体序列的构效关系研究进行了扩展,以考察用磷酸二酯键取代硫代磷酸酯主链连接键的效果,以及在硫代磷酸酯和磷酸二酯寡核苷酸中引入各种2'-糖修饰对寡核苷酸体外抗核酸酶稳定性和细胞内反义活性的影响。用磷酸二酯键取代三个或更多硫代磷酸酯连接键会极大地损害核酸酶抗性和反义活性,且这些效应与寡核苷酸中掺入的磷酸二酯键数量直接相关。然而,通过掺入适当的2'-烷氧基糖修饰,磷酸二酯寡核苷酸获得了足以在细胞中产生有效反义效应的显著核酸酶抗性。这些糖修饰在磷酸二酯主链中赋予的核酸酶稳定性和反义活性与2'-烷氧基取代基的大小相关(戊氧基>丙氧基>甲氧基>脱氧)。此外,对核酸酶降解具有部分抗性的寡核苷酸介导的反义活性取决于寡核苷酸浓度和寡核苷酸处理持续时间。

相似文献

1
Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras.靶向Ha-ras的修饰寡核苷酸的核酸酶抗性和反义活性
J Biol Chem. 1996 Jun 14;271(24):14533-40. doi: 10.1074/jbc.271.24.14533.
2
Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression.评估含有2'-脱氧间隙的2'-修饰寡核苷酸作为基因表达反义抑制剂的作用。
J Biol Chem. 1993 Jul 5;268(19):14514-22.
3
Antisense properties of end-modified oligonucleotides targeted to Ha-ras oncogene.靶向Ha-ras癌基因的末端修饰寡核苷酸的反义特性
Antisense Nucleic Acid Drug Dev. 1997 Aug;7(4):361-8. doi: 10.1089/oli.1.1997.7.361.
4
Antisense oligonucleotides.反义寡核苷酸
Verh K Acad Geneeskd Belg. 1996;58(4):359-81.
5
Optimization of antisense oligodeoxynucleotide structure for targeting bcr-abl mRNA.用于靶向bcr-abl mRNA的反义寡脱氧核苷酸结构的优化
Blood. 1995 Jul 15;86(2):744-54.
6
Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets.均匀修饰的2'-脱氧-2'-氟硫代磷酸酯寡核苷酸作为对RNA靶标具有高亲和力和特异性的抗核酸酶反义化合物。
J Med Chem. 1993 Apr 2;36(7):831-41. doi: 10.1021/jm00059a007.
7
Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modifications.通过掺入2'-O-丙基修饰增强靶向小鼠蛋白激酶C-α的反义寡核苷酸的活性。
Nucleic Acids Res. 1996 Feb 1;24(3):411-7. doi: 10.1093/nar/24.3.411.
8
Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.聚乙烯亚胺而非阳离子脂质可提高3'-帽磷酸二酯寡核苷酸的反义活性。
Antisense Nucleic Acid Drug Dev. 1999 Dec;9(6):515-25. doi: 10.1089/oli.1.1999.9.515.
9
Synthesis of 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl] modified nucleosides and oligonucleotides.2'-O-[2-[(N,N-二甲基氨基)氧基]乙基]修饰核苷和寡核苷酸的合成
J Org Chem. 2002 Jan 25;67(2):357-69. doi: 10.1021/jo0103975.
10
Properties of nicked and circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligodeoxynucleotides.含有反义磷酸二酯寡脱氧核苷酸的带切口和环状哑铃状RNA/DNA嵌合寡核苷酸的特性
Bioorg Med Chem. 1998 Jul;6(7):1025-32. doi: 10.1016/s0968-0896(98)00060-1.

引用本文的文献

1
Chemical Modifications in Nucleic Acid Therapeutics.核酸疗法中的化学修饰
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
In Vitro Structure-Activity Relationship Stability Study of Antisense Oligonucleotide Therapeutics Using Biological Matrices and Nucleases.使用生物基质和核酸酶的反义寡核苷酸疗法的体外构效关系稳定性研究
Pharmacol Res Perspect. 2025 Jun;13(3):e70096. doi: 10.1002/prp2.70096.
3
Rapid generation of homozygous fluorescent knock-in human cells using CRISPR-Cas9 genome editing and validation by automated imaging and digital PCR screening.
使用CRISPR-Cas9基因组编辑技术快速生成纯合荧光敲入人类细胞,并通过自动成像和数字PCR筛选进行验证。
Nat Protoc. 2025 Jan;20(1):26-66. doi: 10.1038/s41596-024-01043-6. Epub 2024 Sep 20.
4
Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease.精准医学与基于核苷酸的疗法治疗脂肪性肝病
Clin Mol Hepatol. 2025 Feb;31(Suppl):S76-S93. doi: 10.3350/cmh.2024.0438. Epub 2024 Aug 5.
5
Three Prime Repair Exonuclease 1 preferentially degrades the integration-incompetent HIV-1 DNA through favorable kinetics, thermodynamic, structural and conformational properties.三磷酸修复外切核酸酶1通过有利的动力学、热力学、结构和构象特性优先降解无整合能力的HIV-1 DNA。
bioRxiv. 2024 Mar 19:2024.03.19.585766. doi: 10.1101/2024.03.19.585766.
6
Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies.通过细胞穿透肽偶联、化学修饰和基于载体的递送策略提高寡核苷酸疗法的有效性
Pharmaceutics. 2023 Apr 3;15(4):1130. doi: 10.3390/pharmaceutics15041130.
7
Selective Inhibition of ADAR1 Using 8-Azanebularine-Modified RNA Duplexes.使用 8-氮杂鸟嘌呤修饰的 RNA 双链体选择性抑制 ADAR1。
Biochemistry. 2023 Apr 18;62(8):1376-1387. doi: 10.1021/acs.biochem.2c00686. Epub 2023 Mar 27.
8
Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display.纳米颗粒疫苗可设计为诱导 pDC 支持 mDC 以增加抗原呈递。
Biomater Sci. 2023 Jan 17;11(2):596-610. doi: 10.1039/d2bm01132h.
9
An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides.一种增强硫代磷酸酯外显子跳跃寡核苷酸细胞摄取和活性的 LNA-酰胺修饰。
Nat Commun. 2022 Jul 12;13(1):4036. doi: 10.1038/s41467-022-31636-2.
10
Exosomally Targeting microRNA23a Ameliorates Microvascular Endothelial Barrier Dysfunction Following Rickettsial Infection.外泌体靶向 microRNA23a 可改善立克次体感染后的微血管内皮屏障功能障碍。
Front Immunol. 2022 Jun 23;13:904679. doi: 10.3389/fimmu.2022.904679. eCollection 2022.